Then, using the comprehensive survival analysis platforms of Kaplan-Meier plotter and PrognoScan, we concluded that decreased mRNA expression of TCF21 is a poor prognostic factor in patients with lung adenocarcinoma. Here, TCF21 is linked to lung adenocarcinoma.